Tolerance development in cow’s milk–allergic infants receiving amino acid–based formula: A randomized controlled trial

医学 牛奶 随机对照试验 婴儿配方奶粉 牛奶过敏 食物过敏 儿科 动物科学 过敏 内科学 食品科学 生物 免疫学
作者
Pantipa Chatchatee,Anna H Nowak-Wegrzyn,Lars Lange,Suwat Benjaponpitak,Kok Wee Chong,Pasuree Sangsupawanich,Marleen T. J. van Ampting,Manon M. Oude Nijhuis,Lucien F. Harthoorn,Jane E. Langford,Jan Knol,Karen Knipping,Johan Garssen,Valérie Trendelenburg,Robert D. Pesek,Carla McGuire Davis,Antonella Maria Muraro,Michel Erlewyn‐Lajeunesse,Adam Tobias Fox,Louise Jane Michaelis
出处
期刊:The Journal of Allergy and Clinical Immunology [Elsevier BV]
卷期号:149 (2): 650-658.e5 被引量:50
标识
DOI:10.1016/j.jaci.2021.06.025
摘要

BACKGROUND: Tolerance development is an important clinical outcome for infants with cow's milk allergy. OBJECTIVE: This multicenter, prospective, randomized, double-blind, controlled clinical study (NTR3725) evaluated tolerance development to cow's milk (CM) and safety of an amino acid-based formula (AAF) including synbiotics (AAF-S) comprising prebiotic oligosaccharides (oligofructose, inulin) and probiotic Bifidobacterium breve M-16V in infants with confirmed IgE-mediated CM allergy. METHODS: Subjects aged ≤13 months with IgE-mediated CM allergy were randomized to receive AAF-S (n = 80) or AAF (n = 89) for 12 months. Stratification was based on CM skin prick test wheal size and study site. After 12 and 24 months, CM tolerance was evaluated by double-blind, placebo-controlled food challenge. A logistic regression model used the all-subjects randomized data set. RESULTS: At baseline, mean ± SD age was 9.36 ± 2.53 months. At 12 and 24 months, respectively, 49% and 62% of subjects were CM tolerant (AAF-S 45% and 64%; AAF 52% and 59%), and not differ significantly between groups. During the 12-month intervention, the number of subjects reporting at least 1 adverse event did not significantly differ between groups; however, fewer subjects required hospitalization due to serious adverse events categorized as infections in the AAF-S versus AAF group (9% vs 20%; P = .036). CONCLUSIONS: After 12 and 24 months, CM tolerance was not different between groups and was in line with natural outgrowth. Results suggest that during the intervention, fewer subjects receiving AAF-S required hospitalization due to infections.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
eeven的应助被初景采纳,获得10
刚刚
刚刚
Maestro_S的应助被研友_842M4n采纳,获得10
1秒前
qingxuan发布了新的文献求助10
1秒前
FossilGitter8发布了新的文献求助10
2秒前
冉123完成签到,获得积分20
2秒前
AquaticLily完成签到,获得积分10
2秒前
xixi完成签到 ,获得积分10
3秒前
3秒前
嘤嘤怪完成签到,获得积分10
4秒前
共享精神的应助被李密采纳,获得10
4秒前
5秒前
水煮电吹风的应助被洋洋洋采纳,获得10
5秒前
wsw111完成签到,获得积分10
5秒前
6秒前
chen完成签到,获得积分10
6秒前
7秒前
xiaoyi发布了新的文献求助10
8秒前
zhaohu47完成签到,获得积分10
8秒前
cdercder的应助被伊莎贝拉采纳,获得10
8秒前
wsw111发布了新的文献求助10
9秒前
9秒前
9秒前
一只咸鱼罢了完成签到,获得积分10
10秒前
打打的应助被LgY采纳,获得10
10秒前
务实成龙完成签到,获得积分10
10秒前
10秒前
将将完成签到,获得积分10
10秒前
11秒前
上官若男的应助被qingxuan采纳,获得10
11秒前
11秒前
luo完成签到,获得积分20
11秒前
搞怪的乐荷完成签到,获得积分10
13秒前
書生途发布了新的文献求助10
14秒前
14秒前
14秒前
wangxiangqin发布了新的文献求助10
15秒前
luo发布了新的文献求助10
15秒前
ws完成签到,获得积分10
15秒前
FossilGitter8完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182014
求助须知:如何正确求助?哪些是违规求助? 9571728
关于积分的说明 21819478
捐赠科研通 7778441
什么是DOI,文献DOI怎么找? 3433580
关于科研通互助平台的介绍 2557781
邀请新用户注册赠送积分活动 2479640